A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

Shixia Wang(Altimmune (United Kingdom)), Farshad Guirakhoo(Dallas VA Medical Center), Kou-Liang Hou(Asia Centre), Chang Yi Wang(Chung Hua University), Alexander Rumyantsev(Altimmune (United Kingdom)), Ming-Han Jiang(Asia University), Alexander Bukreyev(The University of Texas Medical Branch at Galveston), Hui-Kai Kuo(Asia University), Yaw-Jen Liu(CTI BioPharma (Italy)), Natalia A. Kuzmina(Galveston College), Chung Ho Hung(United Biomedical (United States)), Mei Mei Hu(United Biomedical (United States)), Jennifer Cheng(Asia University), Ed Lin(United Biomedical (United States)), Yi‐Ling Lin(Genomics Research Center, Academia Sinica), Chandru Subramani(Galveston College), Shuang Ding(Chinese Academy of Sciences), Wei Xia(Seventh People's Hospital of Shanghai), Zhonghao Shih(CTI BioPharma (Italy)), Valorie Ryan(Altimmune (United Kingdom)), Huang-Ting Wu(Asia Centre), Delphine C. Malherbe(Oregon Health & Science University), Thomas P. Monath(Dallas VA Medical Center), Hui-Jung Chen(CTI BioPharma (Italy)), Michael Hellerstein(ExxonMobil (United States)), Lin Feng(Second Affiliated Hospital of Zhejiang University), Be-Shen Kuo(CTI BioPharma (Italy)), Zhi Liu(United Biomedical (United States)), Ya-Ting Yang(Asia University), Tony Chen(University of Maryland, College Park), Juin-Hua Huang(Asia University), Min-Sheng Wang(Wuhan University), Sivakumar Periasamy(Albany Medical Center Hospital), D. Gray Heppner(Dallas VA Medical Center), Wen‐Jiun Peng(Asia University)

Emerging Microbes & Infections

October 26, 2022

Cited by 33

Related Papers

|Archives of Virology|2016|506

|Archives of Virology|2019|342

|PLoS Pathogens|2012|257

|Archives of Virology|2017|222

|Archives of Virology|2018|202